| Improvement of Metabolic Control and Diabetes Management in Insulin-Treated Patients Results in Substantial Cost Savings for the German Health System |
1 |
| The Interplay between Dysglycaemia and Autonomic Function |
1 |
| Individualised Type 2 Diabetes Treatment in the Elderly: Rational Treatment Goals and Patient Expectations |
1 |
| Patch Pumps: Are They All the Same? |
1 |
| How Digital is Diabetology in Germany? Results from the Digitalisation and Technology Report Diabetes 2019 |
1 |
| Blood Glucose Meter According to the Latest DIN EN ISO Standard: Handling and Safety |
1 |
| Better Glycaemic Control and Faster Therapy Adjustment Using Integrated Personalised Diabetes Management (iPDM): PDM-ProValue Results |
1 |
| Diabetes Metabolism and the Heart Abstracts |
0 |
| A Low-Carbohydrate, Hypocaforic Intervention with Marginal Support Improves Glycaernie Control |
0 |
| 4th CVOT Summit in cooperation with D&CVD EASD Study Group Abstracts |
0 |
| Fast-Acting Insulin aspart (faster aspart) - Clinical Data on Application in Type 1 and 2 Diabetes |
0 |
| ViViCap - Reliable, Reusable Protection against Insulin Degradation in High and Low Ambient Temperatures |
0 |
| Increased Intact Proinsulin as an Early indication of a Future Type 2 Diabetes |
0 |
| Acarbose in Preventive Treatment for Type 2 Diabetes - Update after Evaluating the ACE Study |
0 |
| Anti-Inflammatory vs. Anti-Hormonal Treatment for Diabetic Macular Oedema: Time for a New Approach? |
0 |
| Microvascular Complications of Diabetes: Nephropathy, Retinopathy, and Maculopathy |
0 |
| Remission of Type 2 Diabetes after Long-Term Testosterone Therapy |
0 |
| HYPO-TRIAD: A new Metric for Hypoglycaemic Assessment |
0 |
| Assessing CGM Parameters for Evaluating Diabetes Management |
0 |
| HYPOGONADISM (1) What does Type 2 Diabetes have to do with Testosterone Deficiency? |
0 |
| The MyTherapy App Reinforces Patient Adherence and Physician-Patient Relations in Diabetes |
0 |
| Technology in the Treatment of Type 1 Diabetes mellitus: Does the artificial Pancreas replace the traditional Basic Bolus System? |
0 |
| What Impact does a new Classification of Patients with Type 2 Diabetes mellitus have on the specific Patient Care? |
0 |
| The Telemedical Lifestyle Intervention Program (TeLiPro) Improves Diabetes Management Initially and after Re-Intervention: Data from Three-Year Follow-up |
0 |
| Football Training for Children and Adolescents with Type 1 Diabetes - Benefits and Risks |
0 |
| State of oral Therapy of Type 2 Diabetes |
0 |
| Update of Cardiovascular Outcome Trials (CVOTs) in Diabetes - CVOT Summit 2018 |
0 |
| Updated Statement of the DDG Working Group Diabetes & Technology (AGDT) on the Replacement of Blood Glucose Measurements by Measurements with Systems for continuous real-time Glucose Monitoring (rtCGM) or with intermittent Scanning (iscCGM) |
0 |
| Successful Personalised Type 2 Diabetes Management in Commercial Pilots Using De-Escalation Treatment (DET) to Preserve beta-Cells - Background and Case Studies |
0 |
| The TeLiPro Telemedical Lifestyle Intervention Programme as a Service in Addition to Standard Type 2 Diabetes Care |
0 |
| Pre-Existing Conditions Determining Current Diabetes Therapy: Mitigating Complications Involving the Heart and Kidneys |
0 |
| The challenge of timely diagnosis of distal sensorimotor polyneuropathy in clinical practice |
0 |
| Cold Plasma in the Treatment of Burns |
0 |
| Blood Glucose Monitoring Systems with Voice Guidance |
0 |
| Diabetes mellitus: Thoughts on Nutrition- and Exercise Therapy |
0 |
| Pump Tuning - or Smart Guard as a Glucose Sitter at Night |
0 |
| Biosimilar Insulins: Current Situation |
0 |
| Beneficial Effects of a Topical Foam Cream Product in a Study on Subjects with Type 1 and Type 2 Diabetic Foot Skin Xerosis |
0 |
| 13th Congress of the Central European Diabetes Association/33rd International Danube Symposium, 14-16 June Krakow, Poland -Abstracts- |
0 |
| Sweet Poison - Methylglyoxal and Advanced Glycation Endproducts as Complicating Factors in Diabetes Mellitus |
0 |
| Diabetes, Heart Failure and Natriuretic Peptides |
0 |
| Screening Test Patch for Diabetic Autonomic Neuropathy |
0 |
